戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 finding demonstrates stereoselectivity by an LPA receptor.
2 the GenBankTM for homologs of the human Edg2 LPA receptor.
3 ndicate that Edg-2 encodes a highly specific LPA receptor.
4 it independent regulation of each subtype of LPA receptor.
5 opus that encodes a functional high-affinity LPA receptor.
6 gonucleotide did not affect the low-affinity LPA receptor.
7 ) receptor LPA1/Edg2 is the first identified LPA receptor.
8 rphan receptor GPR92 has properties of a new LPA receptor.
9  protein-dependent pathways activated by the LPA receptor.
10 t difficult to assign a response to specific LPA receptors.
11 ve been identified that encode high-affinity LPA receptors.
12 distinct functions among the three mammalian LPA receptors.
13  new genes that may encode novel subtypes of LPA receptors.
14 hat functions as a mitogen by acting through LPA receptors.
15 ell-cell junctions through Galpha(i)-coupled LPA receptors.
16  in contrast to the motility-stimulating Edg LPA receptors.
17 g that beta-arrestin 2 may recruit CARMA3 to LPA receptors.
18  structurally distant from the canonical Edg LPA receptors.
19 t of endothelial differentiation gene family LPA receptors.
20 ional antagonism between the two subtypes of LPA receptors.
21  through the activation of G protein-coupled LPA receptors.
22 cells, were utilized and compared with known LPA receptors.
23 lso activates cellular targets distinct from LPA receptors.
24 downstream rho signaling by the thrombin and LPA receptors.
25 ired to interact with lysophosphatidic acid (LPA) receptors.
26                            SMCs derived from LPA receptor 1 (LPA1) knock-out mice lack the ability of
27      Pharmacological and genetic blockage of LPA receptor 1 (LPAR1) or autotoxin (ATX), a secretory l
28 gr-1 expression is via LPA cognate receptor (LPA receptor 1)-dependent and PKCdelta-mediated ERK and
29  (hMCs) in vitro through a pathway involving LPA receptors 1 and 3 (termed the LPA(1) and LPA(3) rece
30 ously, we showed that lysophosphatidic acid (LPA) receptor 1 regulates proliferation of intestinal ep
31                            The expression of LPA receptor 2 (LPA2) is up-regulated in several types o
32 rally restricted decrease in the mobility of LPA receptor 2 (LPA2) on chemotactic fibroblasts.
33 his study, we identify the G-protein-coupled LPA receptor 2 (LPAR2) as a signal transducer specifical
34 atidic acid (LPA) driving chemotaxis through LPA receptor 2 and actin cytoskeletal mobilization.
35 adherin downstream of lysophosphatidic acid (LPA) receptor 2.
36                   However, whether different LPA receptors activate distinct anti-apoptotic signaling
37 itive inhibitors of ATX, thereby attenuating LPA receptor activation.
38 tinct subset of ERK1/2-mediated responses to LPA receptor activation.
39 s accomplished by both activation of the Edg/LPA receptor and LPA-mediated transactivation of the epi
40 ion in human thyroid cancers correlated with LPA receptor and markers of aggressiveness including Ki6
41                       Thus, LPA acts through LPA receptor and PPAR-gamma-dependent pathways to accele
42 P(A1)-1 and XLP(A1)-2 are functional Xenopus LPA receptors and demonstrate the evolutionary conservat
43 l via a signaling pathway involving specific LPA receptors and protein kinase D.
44  These data suggest that FAPs are ligands of LPA receptors and that FAP-10 and FAP-12 are the first r
45 o been analyzed and shown to require PLA(2), LPA receptors, and the mitogen-activated protein/extrace
46 ted receptors (PARs), lysophosphatidic acid (LPA) receptors, and sphingosine-1-phosphate (S1P) recept
47 6 and IL-8 generation is mediated by the Edg LPA receptors as enforced expression of LPA receptors re
48                             Of the classical LPA receptors belonging to the Edg family, lpa2 (edg4) i
49 and extend the functionality of LPA(4) as an LPA receptor, bringing the number of independently verif
50 to increased expression of the high-affinity LPA receptor, but activation of the low-affinity recepto
51 y shown to be antagonists for Xenopus laevis LPA receptors, did not antagonize the Ca2+-mobilizing ef
52 the frog oocyte for expression cloning of an LPA receptor DNA, an assay system made problematic by th
53 proach to further elucidate the functions of LPA receptors during red blood cell (RBC) differentiatio
54 encoding the putative lysophosphatidic acid (LPA) receptor Edg-2 (Vzg-1) in Saccharomyces cerevisiae
55  EDG-3, and EDG-5 and lysophosphatidic acid (LPA) receptors EDG-2 and EDG-4 suggested that its ligand
56                    Schwann cells express the LPA receptors (Edg receptors), which, once activated, ha
57 rmal retina has a baseline expression of the LPA receptors, EDG-2 and EDG-4, which are significantly
58 wild-type Gab1 in HEK293 cells augmented the LPA receptor Edg2-mediated ERK2 activation.
59 kinase (ROCK) via the lysophosphatidic acid (LPA) receptor elicits clathrin-dependent Kv1.2 endocytos
60 nm) similar to that of the G protein-coupled LPA receptors encoded by endothelial differentiation gen
61                            Increased ATX and LPA receptor expression have been found in numerous canc
62 es functional distinctions between different LPA receptor family members that are expressed constitut
63                         The first identified LPA receptor gene, lp(A1)/vzg-1/edg-2, was previously sh
64  the first identified lysophosphatidic acid (LPA) receptor gene, lpA1 (also referred to as vzg-1 or e
65  expression pattern with the other two known LPA receptor genes (lp(A1)/Edg2 and lp(A2)/Edg4non-mutan
66         We examined whether any of the known LPA receptor genes (lp(A1)/Edg2, lp(A2)/Edg4, and lp(A3)
67 ghest expression levels of each of the three LPA receptor genes in adult mouse testes, relatively hig
68 subfamily, distinct from that containing the LPA receptor genes lpA1 and lpA2.
69  the present study, mRNA expression of all 6 LPA receptor genes was detected in murine aortic VSMCs,
70  To understand the evolution and function of LPA receptor genes, we characterized lp(A3)/Edg7 in mous
71 R, PSP24, was reported to be a high affinity LPA receptor in Xenopus laevis oocytes, raising the poss
72 strate for the first time the involvement of LPA receptors in mediating surprisingly diverse NPC calc
73 dentified essential biological functions for LPA receptors in mice.
74 -PCR revealed the presence of all five known LPA receptors in primary NPCs, with prominent expression
75                                              LPA receptors in RPE cells activate pertussis toxin (PTx
76 A, which might indicate the existence of two LPA receptors in these cells.
77 e expression of the endogenous high-affinity LPA receptors in Xenopus oocytes, whereas the same oligo
78 ry evidence that supports LPA(4) as a fourth LPA receptor, including LPA concentration-dependent resp
79   Here, we review current knowledge on these LPA receptors, including their isolation, function, expr
80 te the transcriptional mechanism and the Edg LPA receptors involved in LPA-induced IL-6 and IL-8 prod
81                            We also evaluated LPA receptor involvement.
82                     There are currently four LPA receptors known as LPA(1-4).
83  a competitive inhibitor for the endothelial LPA receptor, loss of confluence in vitro and the hydrau
84  receptors have been identified as mammalian LPA receptors: LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(
85                            Expression of the LPA receptor LPA(5) was necessary for LPA-induced stimul
86                                          Two LPA receptors, LPA(1) and LPA(2), are expressed in the e
87 103 neuroblastoma cells devoid of endogenous LPA receptors, LPA(4) attenuated LPA(1)-driven migration
88                   The lysophosphatidic acid (LPA) receptor LPA1/Edg2 is the first identified LPA rece
89 g transplant model of BOS, antagonism of the LPA receptor (LPA1) or ATX inhibition decreased allograf
90 ly act as agonists for the G-protein-coupled lpA receptors (LPA1, LPA2, and LPA3) and s1p receptors (
91 ere we show, for the first time, that type 2 LPA receptors (LPA2) are expressed at the apical surface
92 lantation through the lysophosphatidic acid (LPA) receptor LPA3.
93       These results support GPR92 as a fifth LPA receptor, LPA5, which likely has distinct physiologi
94                  This study determined which LPA receptor (LPAR) subtype(s) LPA signals through to st
95  other ccPA analogues were characterized for LPA receptor (LPAR) subtype-specific agonist and antagon
96  by activation of the lysophosphatidic acid (LPA) receptor (LPAR) via SRC-dependent transactivation o
97 sophosphatidic acid (LPA) acting through the LPA receptor LPAR1.
98  wound-healing model; and 3) to identify the LPA receptors (LPARs) expressed by PDLF.
99 c acid (LPA) functions through activation of LPA receptors (LPARs).
100 GTPases through binding to G-protein-coupled LPA receptors (LPARs).
101 3T3 cells was mediated by the stimulation of LPA-receptors (LPARs) by LPA in the serum.
102 st cell lines in culture express one or more LPA receptors, making it difficult to assign a response
103 ession of structurally different subtypes of LPA receptors may provide one basis for tissue-specific
104  of both LPA-producing enzymes or of several LPA receptors may reveal the functional role of LPA sign
105 he mechanisms and specificity by which these LPA receptors mediate LPA actions are still poorly under
106 iates most of its biological effects through LPA receptors, of which six isoforms have been identifie
107 Our findings provide evidence for functional LPA receptors on microglia.
108                                              LPA receptors on platelets, leukocytes, endothelial cell
109      The opposite effects of Edg-2 and Edg-4 LPA receptors on trans-Matrigel migration and some other
110 (Neu*) or the ligand-dependent activation of LPA receptors or muscarinic receptors, which are two cla
111 ous G protein-coupled lysophosphatidic acid (LPA) receptors or by transient expression of Gbetagamma
112                      In RH7777 cells lacking LPA receptors, OTP selectively protected LPA(2) but not
113 of LPA on GROalpha expression is mediated by LPA receptors, particularly the LPA(2) receptor in that
114          Thrombin and lysophosphatidic acid (LPA) receptors play important roles in vascular biology,
115  Edg LPA receptors as enforced expression of LPA receptors restored LPA-induced IL-6 and IL-8 product
116 vity of extracellular autotaxin (ATX), binds LPA receptors, resulting in an array of biological actio
117 sible photoreactive alkylating agent for the LPA receptor(s).
118 ion of novel agonists and antagonists of the LPA receptor(s).
119 the free hydroxyl group in order to evaluate LPA receptor SAR.
120 1-phosphate (S1P) and lysophosphatidic acid (LPA) receptor sequences were used to design semi-redunda
121                                          ATX-LPA receptor signaling is essential for normal developme
122                   These results suggest that LPA receptor signaling may play an important role in neu
123  with and potentiates lysophosphatidic acid (LPA) receptor signaling to the downstream effector RHOA.
124 ICl(LPA) in a dose-dependent manner, and the LPA receptor-specific antagonist dioctyl-glycerol pyroph
125  of beta-arrestins in lysophosphatidic acid (LPA) receptor-stimulated ERK1/2 activation using fibrobl
126         MAP kinase activation resulting from LPA receptor stimulation, expression of Gbetagamma subun
127 se, glutamine 125, which is conserved in the LPA receptor subfamily (LPA(1)/EDG2, LPA(2)/EDG4, and LP
128 action of LPA is mediated through LPA(2), an LPA receptor subtype overexpressed in ovarian cancer and
129 gnaling in neuropathic pain through a second LPA receptor subtype, LPA(5), involving a mechanisticall
130 operties of LPA has been hampered by lack of LPA receptor subtype-specific agonists and antagonists.
131 riments showed the presence of RNA for three LPA receptor subtypes (Edg2, -4, and -7); RNase protecti
132  vascular injury but suggest that additional LPA receptor subtypes are required for other LPA-mediate
133                    LPA(2) differs from other LPA receptor subtypes in the C-terminal tail, where it c
134            The pharmacological activation of LPA receptor subtypes represent a novel strategies for a
135 LPA exhibits agonistic activity on all three LPA receptor subtypes, whereas OMPT has a potent agonist
136 y dermal and epidermal expression of several LPA receptors, suggesting that LPA signaling could contr
137  in EC(50) in response to LPA but caused the LPA receptors to become more responsive to sphingosine 1
138 ringing the number of independently verified LPA receptors to five, with both overlapping and distinc
139                                              LPA receptor transduction was analyzed in human and rat
140    This study reveals that LPA signaling via LPA receptor type 1 activation causes demyelination and
141 LPA) is a potent inducer of colon cancer and LPA receptor type 2 (LPA(2)) is overexpressed in colon t
142  Analysis of this series at each recombinant LPA receptor using a guanosine 5'-O-(3-[35S]thio)triphos
143                       Toward identifying new LPA receptors, we have screened collections of GPCR cDNA
144 A1/vzg-1 in the VZ suggested that functional LPA receptors were synthesized at these early times, and
145 to examine the functional interaction of the LPA receptor with G proteins in intact mouse fibroblasts
146  of cPA lack significant agonist activity at LPA receptors yet are potent inhibitors of ATX activity,

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top